Initial Testing Finds Moderna’s COVID-19 Vaccine to be 94.5% Effective

Early data from Moderna finds that its potential COVID-19 vaccine, dubbed mRNA-1273, has a high success rate and is almost 95% effective, leapfrogging Pfizer’s data report of being 90% effective. Moderna’s trial consisted of 30,000 test participants, of which 15,000 were given a placebo. The months following saw 90 of them contracted COVID-19, while 11…